Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer: proof-of-principle

Triple-negative breast cancer (TNBC) remains difficult to treat, especially due to ineffective immune responses. Current treatments mainly aim at a cytotoxic effect, whereas (stem) cell therapies are being investigated for their immune stimulatory capacities to initiate the anti-tumor immunity. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Steenbrugge, Jonas, Pauwelyn, Glenn, Demeyere, Kristel, Devriendt, Nausikaa, de Rooster, Hilde, Sanders, Niek N., Spaas, Jan H., Meyer, Evelyne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623058/
https://www.ncbi.nlm.nih.gov/pubmed/37928528
http://dx.doi.org/10.3389/fimmu.2023.1252374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623058/
https://www.ncbi.nlm.nih.gov/pubmed/37928528
http://dx.doi.org/10.3389/fimmu.2023.1252374

Ejemplares similares